Addus HomeCare (ADUS) to Release Earnings on Monday

Addus HomeCare (NASDAQ:ADUS) is scheduled to post its quarterly earnings results after the market closes on Monday, May 6th. Analysts expect Addus HomeCare to post earnings of $0.97 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, February 26th. The company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.17. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. The company had revenue of $276.35 million for the quarter, compared to analyst estimates of $274.02 million. On average, analysts expect Addus HomeCare to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Addus HomeCare Trading Down 0.2 %

Shares of ADUS stock opened at $98.20 on Friday. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. The company has a market capitalization of $1.61 billion, a price-to-earnings ratio of 25.57, a PEG ratio of 1.94 and a beta of 0.96. Addus HomeCare has a 52-week low of $77.30 and a 52-week high of $104.61. The company has a 50-day simple moving average of $98.27 and a two-hundred day simple moving average of $92.26.

Analyst Upgrades and Downgrades

ADUS has been the subject of several recent analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $102.00 target price on shares of Addus HomeCare in a report on Thursday, February 29th. William Blair reaffirmed an “outperform” rating on shares of Addus HomeCare in a research report on Monday, February 5th. Oppenheimer reissued an “outperform” rating and issued a $118.00 price target on shares of Addus HomeCare in a report on Tuesday, March 26th. Finally, Barclays downgraded shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective for the company. in a report on Tuesday, April 23rd. One equities research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $103.00.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.